Financial Results of Ultradata Systems Inc., Intensiva Healthcare Corp., Pulaski Bank, and Sheffield Pharmaceuticals Inc.

Strategic Insights -

Ultradata Systems Inc., a leading manufacturer of hand-held computerized travel information devices, reported a disappointing third-quarter loss of $325,000, or 10 cents a share, compared to last year's third-quarter profit of $105,804, or 3 cents a share. The company's failure to market its new product, TravelStar, which combines Global Positioning Satellite technology with its travel database products, on schedule contributed to the loss. Meanwhile, Intensiva Healthcare Corp., a long-term acute care provider, reported a 50 percent jump in revenue in the third quarter, with earnings increasing to 12 cents a share from 7 cents. In contrast, Pulaski Bank reported a decline in earnings of $124,500, or 17 cents a share, due to increased non-interest expenses, while Sheffield Pharmaceuticals Inc. posted a third-quarter loss, citing plans to minimize infrastructure expenses and create a pipeline of new product opportunities.

Key Takeaways:

  • Ultradata Systems Inc. reported a third-quarter loss of $325,000, or 10 cents a share, due to delays in marketing its new product, TravelStar.
  • Intensiva Healthcare Corp. reported a 50 percent jump in revenue in the third quarter, with earnings increasing to 12 cents a share from 7 cents.
  • Pulaski Bank's earnings declined to $369,500, or 17 cents a share, due to increased non-interest expenses.
  • Sheffield Pharmaceuticals Inc. posted a third-quarter loss, citing plans to minimize infrastructure expenses and create a pipeline of new product opportunities.
  • Intensiva Healthcare Corp. is being acquired by Select Medical Corp. for approximately $110 million.
  • Pulaski Bank experienced a 66 percent increase in loan volume and a 5 percent increase in deposits in its fourth quarter.
  • Pulaski Bank's promotion efforts resulted in 65 percent more checking accounts by the end of the year compared to September 30, 1997.

Statistics:

  • Ultradata Systems Inc.'s third-quarter loss: $325,000.
  • Ultradata Systems Inc.'s third-quarter profit last year: $105,804.
  • Intensiva Healthcare Corp.'s third-quarter revenue increase: 50 percent.
  • Intensiva Healthcare Corp.'s third-quarter earnings per share increase: 5 cents (from 7 cents to 12 cents).
  • Pulaski Bank's fourth-quarter earnings decline: $124,500.
  • Pulaski Bank's fourth-quarter earnings per share: 17 cents.
  • Pulaski Bank's fourth-quarter loan volume increase: 66 percent.
  • Pulaski Bank's fourth-quarter deposit increase: 5 percent.
  • Pulaski Bank's checking accounts by the end of the year: 65 percent more than September 30, 1997.
  • Sheffield Pharmaceuticals Inc.'s third-quarter research and development costs: $960,000.
  • Sheffield Pharmaceuticals Inc.'s third-quarter research and development costs last year: $570,000.

Sources:

  • Ultradata Systems Inc.
  • Intensiva Healthcare Corp.
  • Pulaski Bank
  • Sheffield Pharmaceuticals Inc.